Wynn Capital’s Biogen BIIB Stock Holding History

Wynn Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,316	Closed	-$201K	–	109
2024 Q4	$201K	Sell	1,316 -260	-16%	-$43.9K	0.13%	105
2024 Q3	$305K	Hold	1,576	–	–	0.2%	94
2024 Q2	$365K	Sell	1,576 -15	-0.9%	-$3.26K	0.27%	73
2024 Q1	$343K	Sell	1,591 -167	-9%	-$39.1K	0.27%	75
2023 Q4	$455K	Buy	+1,758	New	+$432K	0.37%	63

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wynn Capital's BIIB Position: Q1 2025 in Review

Wynn Capital sold out of Biogen (BIIB) in Q1 2025, closing a stake of 1,316 shares — an estimated $201K sold.

Wynn Capital first reported a position in BIIB in Q4 2023 and held it in 5 quarters. The position peaked at $455K in Q4 2023. 883 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

Wynn Capital reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
Wynn Capital sold 1,316 Biogen shares in Q1 2025, an estimated $201K.
Wynn Capital first reported a position in Biogen in Q4 2023 and held it in 5 quarters.
Wynn Capital's Biogen position peaked at $455K in Q4 2023.
883 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Wynn Capital's 13F filing for Q1 2025, filed 14 Apr 2025.